Qiagen announced CE-IVD certification for its QiaStat-Dx BCID GN Plus AMR Panel, extending the company’s rapid molecular coverage for bloodstream infections. The panel is designed to detect 13 gram-negative bacterial targets and 18 AMR markers from positive blood cultures in roughly one hour. Qiagen said the panel complements its earlier CE-IVD certified QiaStat-Dx BCID GPF Plus AMR Panel, which targets 20 gram-positive bacterial and fungal pathogens and 10 AMR markers. Both run on Qiagen’s PCR-based QiaStat-Dx system. For lab operators and developers, the certification reinforces the move toward faster pathogen-and-resistance reporting to support antimicrobial stewardship and infection control decisions at the point of care.